Utama › Glaukoma Sudut Terbuka › Pennsylvania
Kajian klinikal Glaukoma Sudut Terbuka di Pennsylvania
6 kajian untuk Glaukoma Sudut Terbuka sedang mencari peserta di lokasi di Pennsylvania.
Bandar di Pennsylvania
Teks kajian rasmi (Bahasa Inggeris)
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
- Ophthalmic Partners of PA /ID# 276059, Bala-Cynwyd
- Wills Eye Hospital /ID# 268569, Philadelphia
Mengambil pesertaFasa 3
Umur 45 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06822738Hydrus® Microstent New Enrollment Post-Approval Study
- Scott & Christie and Associates, PC, Cranberry Township
Mengambil peserta
Umur 45 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT04553523Caffeine Consumption in Glaucoma Patients and Healthy Subjects
- Wills Eye Glaucoma Service, Philadelphia
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 hingga 90 · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT03675412Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
- Scheie Eye Institute, Philadelphia
- Wills Eye Hospital, Philadelphia
Mengambil peserta
Umur 45 ke atas · Semua jantina · Dikemas kini 15 Dis 2025 · NCT07220876Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma
- Wills Eye Hosital Glaucoma Dept., Philadelphia
Mengambil pesertaFasa 4
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Nov 2025 · NCT07228221A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Pressure (IOP) Reduction Without Medications at 6 Months in Naive, Untreated Glaucoma Patients
- Shafer Vision Institute, Plymouth Meeting
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Jul 2025 · NCT07076303Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.